2Q26E: EPS revision summary for SCHW IBKR AMP RJF CNS

研报英文原文证据摘录

2Q26E: EPS revision summary for SCHW IBKR AMP RJF CNS

itten consent of BofA Securities.

This document provides general information only, and has been prepared for, and is intended for general distribution to, BofA Securities clients. Neither the information nor any opinion

expressed constitutes an offer or an invitation to make an offer, to buy or sell any securities or other financial instrument or any derivative related to such securities or instruments (e.g., options,

futures, warrants, and contracts for differences). This document is not intended to provide personal investment advice and it does not take into account the specific investment objectives,

financial situation and the particular needs of, and is not directed to, any specific person(s). This document and its content do not constitute, and should not be considered to constitute,

investment advice for purposes of ERISA, the US tax code, the Investment Advisers Act or otherwise. Investors should seek financial advice regarding the appropriateness of investing in financial

instruments and implementing investment strategies discussed or recommended in this document and should understand that statements regarding future prospects may not be realized. Any

decision to purchase or subscribe for securities in any offering must be based solely on existing public information on such security or the information in the prospectus or other offering

document issued in connection with such offering, and not on this document.

Securities and other financial instruments referred to herein, or recommended, offered or sold by BofA Securities, are not insured by the Federal Deposit Insurance Corporation and are not

deposits or other obligations of any insured depository institution (including, Bank of America, N.A.).